Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
[Thiazide diuretics in the treatment of hypertensive patients]
1Medicinsk Afdeling, Roskilde Sygehus, Køgevej 7-13, 4000 Roskilde. kra@regionsjaelland.dk.
Insights
Thiazide diuretics, like hydrochlorothiazide, effectively lower blood pressure in hypertensive patients. Higher doses demonstrate a greater blood pressure reduction compared to placebo.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Hypertension is a major risk factor for cardiovascular disease.
- Diuretics are a common class of antihypertensive medications.
Purpose of the Study:
- To evaluate the dose-response relationship of thiazide diuretics on blood pressure reduction.
- To compare the efficacy of thiazide diuretics against placebo in hypertensive patients.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials.
- Inclusion of studies comparing thiazide diuretics with placebo in adult hypertensive patients.
Main Results:
- Hydrochlorothiazide demonstrated a dose-dependent reduction in blood pressure.
- Doses of 6.25, 12.5, 25, and 50 mg/day resulted in mean reductions of 4/2, 6/3, 8/3, and 11/5 mmHg, respectively.
- These reductions exceeded those observed with other antihypertensive classes like ACE inhibitors and ARBs.
Conclusions:
- Thiazide diuretics provide a significant and dose-related blood pressure lowering effect.
- Hydrochlorothiazide is an effective treatment for hypertension, with greater efficacy at higher doses.
Abstract:
This Cochrane review had the objectives to determine the dose-related decrease in blood pressure due to thiazide diuretics compared with placebo control in the treatment of hypertensive patients. Hydrochlorothiazide has a dose-related blood pressure-lowering effect over the dose range 6.25, 12.5, 25 and 50 mg/day of 4/2, 6/3, 8/3 and 11/5 mmHg, respectively. This exceeds the mean 3 mmHg reduction achieved by angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers as shown in other Cochrane reviews, which have compared these antihypertensive drugs with placebo having used similar inclusion/exclusion criteria.
Related Concept Videos
Antihypertensive Drugs: Thiazide-Class Diuretics
Antihypertensive Drugs: Action of Diuretics
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure V: Medical Management

